ScanSource (SCSC) has just posted its Q2 2026 numbers, reporting revenue of US$766.5 million and basic EPS of US$0.75, alongside trailing twelve month revenue of about US$3.0 billion and EPS of US$3.30. The company has seen quarterly revenue move between US$704.8 million and US$812.9 million over the past six reported periods, while basic EPS has ranged from US$0.70 to US$0.90. This puts the focus on how efficiently that revenue is converting into profit, with margins a key consideration as the latest figures clarify how much of the top line is translating into returns for shareholders.
See our full analysis for ScanSource.With the headline numbers on the table, the next step is to see how this earnings release compares with the most common narratives around ScanSource, and where the data may support or challenge those views.
Curious how numbers become stories that shape markets? Explore Community Narratives
Margins Edge Up To 2.4%
- Over the last 12 months, ScanSource converted US$3.0b of revenue into US$73.9 million of net income, giving it a 2.4% net margin compared with 2.1% a year earlier.
- What stands out for a bullish take is that this higher 2.4% margin sits alongside 17.4% trailing earnings growth and five year annualized earnings growth of 19.9%. This supports the idea of a business that has been steadily strengthening profitability even while operating on relatively thin distributor margins.
- The trailing twelve month EPS of US$3.30, built on revenue of just over US$3.0b, lines up with the view that earnings quality is high rather than one off.
- Net income of US$73.9 million against trailing revenue above US$3.0b also fits a story of incremental margin improvement rather than aggressive cost cutting or financial engineering.
P/E Of 11.2x Versus 26.2x Sector
- ScanSource trades on a trailing P/E of 11.2x, which is below the reported US electronic industry average of 26.2x and the peer average of 16.5x, while the DCF fair value of US$36.79 is slightly under the current share price of US$38.39.
- For a more cautious or bearish angle, critics highlight that the stock price sitting above the DCF fair value and below sector P/E multiples can send mixed signals about how much of its earnings track record is already reflected in the price.
- The US$38.39 share price compared with the US$36.79 DCF fair value suggests the market is paying a small premium to that cash flow estimate, even though the earnings multiple is lower than the 19.3x broader US market figure.
- At the same time, an 11.2x P/E attached to trailing EPS of about US$3.30 indicates investors are not giving it the higher multiples seen in some peers, despite the 17.4% earnings growth cited over the past year.
Slower Forecast Growth Versus Market
- Forecasts in the provided data point to earnings growth of about 9.16% per year and revenue growth of about 3.5% per year, both below the cited US market expectations of 15.6% earnings growth and 10.2% revenue growth.
- Consensus style thinking often views this combination as a trade off between a strong track record and calmer years ahead, and the numbers here give you a clear view of that balance.
- Trailing twelve month earnings growth of 17.4% and EPS of about US$3.30 contrast with the lower forward growth projections, which could limit how far the valuation stretches relative to faster growing names.
- With net profit margin at 2.4% and revenue around US$3.0b on a trailing basis, the business is already operating at a scale where even mid single digit revenue growth can still add meaningful absolute dollars, but not at the pace implied for the broader US market.
Next Steps
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on ScanSource's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
See What Else Is Out There
The forecasts showing slower earnings and revenue growth than the broader US market highlight that ScanSource may not offer the strongest growth profile from here.
If that growth outlook feels a bit restrained for your goals, pull up our 53 high quality undervalued stocks to quickly spot companies where current prices look more appealing relative to their potential.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com